SK chemicals is developing market infrastructure and reinforcing its R&D efforts and resources to develop new vaccines and biomedicines. Medicine in the past used to focus almost exclusively on eliminating diseases, without much regard for the physical pain, complications, and side effects that resulted from it in consequence. Outgrowing this paradigm on medicine, SK chemicals decided to develop and distribute vaccines that are the easiest and most economical way of preventing diseases. In partnership with multinational pharmaceutical giants, SK chemicals has developed and launched 11 basic vaccines that are indispensable to public health. These include the mandatory vaccines for hepatitis B, chickenpox, diphtheria, tetanus, and pertussis (DTP), polio, measles, mumps, and rubella (MMR), tetanus and diphtheria (Td), and so forth, as well as the basic vaccines against meningitis and influenza.
|Photo||Product name||Go link|
(Cell cultured influenza vaccine)
|SKYCellflu Quadrivalent prefilled syringe
Adsorbed tetanus-diphtheria combined toxoid for adult
|HEPAMUN prefilled syringes
Hepatitis B vaccine